AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 114 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $907,644 | -42.7% | 142,264 | -0.5% | 0.00% | 0.0% |
| Q2 2023 | $1,585,249 | -24.0% | 142,944 | +5.2% | 0.00% | 0.0% |
| Q1 2023 | $2,086,664 | -31.6% | 135,939 | +0.6% | 0.00% | -50.0% |
| Q4 2022 | $3,051,536 | +100.5% | 135,090 | +47.7% | 0.00% | +100.0% |
| Q3 2022 | $1,521,864 | +15.3% | 91,468 | -0.5% | 0.00% | 0.0% |
| Q2 2022 | $1,319,422 | -11.4% | 91,951 | +12.0% | 0.00% | 0.0% |
| Q1 2022 | $1,488,868 | +215.4% | 82,116 | +316.0% | 0.00% | – |
| Q4 2021 | $472,000 | -3.1% | 19,741 | -0.1% | 0.00% | – |
| Q3 2021 | $487,000 | +16.0% | 19,767 | +16.3% | 0.00% | – |
| Q2 2021 | $420,000 | +13.2% | 16,997 | -0.1% | 0.00% | – |
| Q1 2021 | $371,000 | +49.6% | 17,021 | +75.3% | 0.00% | – |
| Q4 2020 | $248,000 | -0.8% | 9,711 | +9.3% | 0.00% | – |
| Q3 2020 | $250,000 | – | 8,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,571,160 | $40,096,000 | 20.10% |
| Aaron Wealth Advisors LLC | 524,239 | $13,378,000 | 4.90% |
| Octagon Capital Advisors LP | 430,041 | $10,975,000 | 3.80% |
| EcoR1 Capital, LLC | 2,103,950 | $53,693,000 | 2.89% |
| RTW INVESTMENTS, LP | 3,995,000 | $101,952,000 | 1.71% |
| ACUTA CAPITAL PARTNERS, LLC | 246,200 | $6,283,000 | 1.71% |
| Cormorant Asset Management, LP | 2,464,547 | $62,895,000 | 1.50% |
| Logos Global Management LP | 671,454 | $17,136,000 | 1.47% |
| Boxer Capital, LLC | 1,121,327 | $28,616,000 | 0.92% |
| HighVista Strategies LLC | 26,665 | $680,000 | 0.43% |